Preliminary proxy statement
Open the filing on sec.gov
Adagio Medical Holdings, Inc (ADGM)
Nasdaq: ADGM · Surgical & Medical Instruments & Apparatus · Laguna Hills, CA · filing with the SEC since 2024
The companyfiscal 2025, as filed
Revenue$0.00-100.0%
Net income-$25.1M+31.4%
Earnings per share$-1.51+96.9%
Operating cash flow-$19.0M+25.9%
Cash$17.1M-16.9%
Debt$21.0M+22.5%
Shareholders’ equity$12.4M-37.7%
Shares, diluted16.6M+2081.7%
Return on equity-202.3%
The recordfrom its filings
Filings in 202651
Newest filingNov 10 · PRE 14A
Annual reportMar 27, 2026
Quarterly reportAug 11, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$200,000
Patents grantedn/a
Filer category<br>Emerging growth company
Trailing twelve months to Jun 2026Revenue $0.00Net income -$27.1MCash from operations -$16.5Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Proxy statement
Open the filing on sec.gov
Preliminary proxy statement
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.